Rexahn Pharmaceuticals IncAdd to My Watchlist

RNN:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 0.46
  • 0.02  4.12%
    Today's Change
  • 0.45
    Previous Close
  • Today
    52 Week Low - High
5:15 pm ET 11/27/2015
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding197 million
Market Cap$92 million
Return on Equity ttm-59.36%
Last DividendRNN:US does not pay a dividend
EPS: Year Actual ttm-0.070
EPS: Year Est. 12/15 ttm-0.090
EPS: Quarterly Actual 9/15 -0.02
EPS: Quarterly Est. 12/15 -0.03
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-57.14
Company Description
Rexahn Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops signal inhibitor therapies for cancer, and treatments for central nervous system diseases.
Net Income$-19 million
Total Assets$34 million

Latest Headlines

No news available.


    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now


    Not Registered?

    Get complete access to The Washington Post online - it's FREE!